Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

NICE publishes guideline on recognising neurological conditions

NICE has published a new guideline (NG127) on the recognition and referral of patients with suspected neurological conditions. The guidance aims to help...Read more

CHMP recommends conditional marketing authorisation for cemiplimab for squamous cell carcinoma

The CHMP has recommended the granting of a conditional marketing authorisation for cemiplimab (Libtayo) for the treatment of advanced cutaneous squamous cell...Read more

MHRA warns of yellow fever vaccine risk

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning following two recent reports of fatal adverse reactions to the yellow fever...Read more

EMA restricts use of MS drug alemtuzumab

The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently conducting a review of the safety of the multiple sclerosis (MS) medicine...Read more

CHMP recommends buprenorphine implant for opioid dependence

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a marketing authorisation for Sixmo, a buprenorphine implant...Read more

Featured Articles

Prioritising research into age-related macular degeneration
As life expectancy increases, the number of people living with age-related macular degeneration is set to rise dramatically, meaning it could become the next public health crisis. Existing treatments are of limited benefit, but researchers are exploring several avenues that could lead to new therapies.
Click here to view

Medicines optimisation in East Sussex care homes
Clinical pharmacists now have an important role in medicines optimisation within the care home setting. In this article, the authors discuss their approach to medication reviews and medicines optimisation in care homes in East Sussex.
Click here to view

Management of the idiopathic inflammatory myopathies
The idiopathic inflammatory myopathies (IIMs) – comprising polymyositis, dermatomyositis and inclusion body myositis – are a rare group of disorders characterised by muscle inflammation. This article discusses the causes, symptoms, assessment and treatment of these disorders, and the GP’s role in management.
Click here to view

Web design and marketing agency Leamington Spa